By revealing the role of the carotid body and V1aRs in the pressor and respiratory effects of vasopressin, our study provides a new framework for developing targeted therapies aimed specifically at the carotid bodies and vasopressin V1a receptors for managing hypertension and related respiratory issues. The gene discussed is AVPR1A; the disease is Hypertension.